BMLBMLKF 79 Receivables Turnover is 1.27 as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 79/100 and a GF Value™ of $26.53. The stock has 2 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, BML ranks better than 52.22% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. BML's Revenue for the
three
months ended in Mar. 2026 was $225.5 Mil. BML's average Accounts Receivable for the
three
months ended in Mar. 2026 was $177.3 Mil.
Hence, BML's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.27.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
BML Receivables Turnover Related Terms
BML Receivables Turnover Historical Data
* Premium members only.
The historical data trend for BML's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMLKF vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, BML's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BML Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BML's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where BML's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BML (BMLKF) has a Receivables Turnover of 1.27 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on BML and its competitors. According to the industry distribution chart, BML ranks #97 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 47.8%.
Is BML's Receivables Turnover too high?
BML's current Receivables Turnover is 1.27. The Medical Diagnostics & Research industry median Receivables Turnover is 5.39. BML's value of 1.27 is 76.4% below this industry median. Based on the distribution chart, BML ranks #97 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, BML has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does BML's Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BML ranks #97 out of 203 companies for Receivables Turnover. This puts BML in the upper half of its industry. The industry median Receivables Turnover is 5.39. BML's value of 1.27 is 76.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.39, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BML's current Receivables Turnover of 1.27 is 76.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on BML and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BML's current Receivables Turnover is 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current Receivables Turnover of 1.27. The stock's GF Value™ is $26.53, compared to a current price of $25.21 — trading 5% below its estimated fair value. The current Receivables Turnover is 1.27 and 76.4% below the Medical Diagnostics & Research industry median of 5.39. BML's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For BML (BMLKF), the current Receivables Turnover is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BML (BMLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BML stock appears to be undervalued.
The current stock price of $25.21 is trading 5% below its estimated GF Value™ of $26.53.
Key valuation signals for BMLKF:
Receivables Turnover: 1.27
GF Value™: $26.53 vs. price of $25.21 (5% below fair value)
Industry Position: 76.4% below the Medical Diagnostics & Research median (#97 of 203)
No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
79GF Score
Get the complete analysis for BMLKF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMLKF has been successfully added to your 
